Related Experiment Videos

Enhanced sensitivity to digoxin in dystrophic mice

Japanese Heart Journal
|September 1, 1984
PubMed

Insights

Dystrophic mice exhibit heightened sensitivity to digoxin, a heart medication. This increased sensitivity is not linked to altered digoxin levels or potassium in heart muscle, but rather to longer action potential durations.

Area of Science:

  • Cardiology
  • Pharmacology
  • Genetics

Background:

  • Digoxin is a cardiac glycoside used to treat heart conditions.
  • Duchenne muscular dystrophy (DMD) is a genetic disorder affecting muscle function.
  • The cardiac effects of digoxin in dystrophic models require further investigation.

Purpose of the Study:

  • To investigate the impact of digoxin on myocardial potassium content and cardiac action potentials in dystrophic mice.
  • To determine the underlying mechanisms of potential digoxin hypersensitivity in this model.

Main Methods:

  • Intraperitoneal injection and ex vivo perfusion of digoxin in dystrophic (dy/dy) and normal mice.
  • Measurement of myocardial digoxin and potassium concentrations.
  • Electrophysiological recordings of left ventricular papillary muscle action potentials.

Main Results:

  • Dystrophic mice showed significantly longer action potential durations (APD) compared to normal mice.
  • Intraperitoneal digoxin injection was lethal to all dystrophic mice at a sub-lethal dose for normal mice.
  • Digoxin perfusion shortened APD and induced arrhythmias in dystrophic mice, but not in normal mice.
  • Myocardial digoxin and potassium levels were similar between dystrophic and normal mice post-injection.

Conclusions:

  • Dystrophic mice display increased sensitivity to digoxin.
  • This hypersensitivity is not attributable to altered myocardial digoxin uptake or potassium content.
  • The prolonged APD in dystrophic mice may contribute to their heightened susceptibility to digoxin toxicity.

Related Concept Videos